Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids. Its proprietary Cellgorithm platform uses a CRISPR-based system to accelerate and scale stem cell differentiation, transforming how regenerative medicines are discovered and manufactured. By replacing slow, manual differentiation processes with a rapid, programmable approach that mimics human development, Syntax makes cell generation faster, more reliable, and accessible, unlocking new transformative possibilities for biopharma developers and patients.
| Website | https://www.syntax-bio.com/ |
| Employees | 14 (9 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Stem Cells, Stem Cell Therapy, Cell Differentiation, Advanced Therapy Medicinal Products, Regenerative Medicine, Cell Therapies, Biotechnology, Pharmaceutical Research, Drug Development, Biopharmaceutical, Life Sciences, Therapeutic Innovation, Clinical Development, Biomedical Research, Translational Research, Cell Engineering, Molecular Biology, Cellular Reprogramming, Gene Therapy |
| Competitors | Vertex Pharmaceuticals, Alnylam Pharmaceuticals, Intellia Therapeutics, Inc., CRISPR Therapeutics, Amgen, bluebird bio, Editas Medicine, Sangamo Therapeutics, Inc., Moderna Therapeutics, Aduro Biotech is now Chinook Therapeutics +37 more (view full list) |
Looking for a particular Syntax Bio employee's phone or email?
Syntax Bio Questions
John Craighead is the CEO of Syntax Bio.
9 people are employed at Syntax Bio.
Syntax Bio is based in Chicago, Illinois.
Top Syntax Bio Employees
-
John Craighead
Chief Executive Officer at Syntax Bio
California, United States5 -
13
-
2
-
Brad Merrill
Head of Innovation at Syntax Bio
Oak Park, IL, US33 -
Renee de Pooter
Senior Principal Scientist at Syntax Bio
Chicago, IL, US1 -
Caspian Harding
Scientist, Stem Cell Biology at Syntax Bio
Chicago, IL, US12 -
Michaele McGregor
Associate Scientist at Syntax Bio
Chicago, IL, US11
